Angella Sutthiwan serves as the Vice President and General Manager at PCI Pharma Services, where she leverages over 17 years of diverse experience in operations and project management within the pharmaceutical industry. With a robust background in continuous improvement and operational excellence, Angella is dedicated...
Angella Sutthiwan serves as the Vice President and General Manager at PCI Pharma Services, where she leverages over 17 years of diverse experience in operations and project management within the pharmaceutical industry. With a robust background in continuous improvement and operational excellence, Angella is dedicated to maximizing growth and profitability while maintaining the highest standards of safety and quality. Her leadership is characterized by a strong commitment to fostering a culture of continuous improvement, ensuring that PCI Pharma Services not only meets but exceeds customer expectations.
In her current role, Angella spearheads key projects that enhance operational efficiency and drive innovation across the organization. Her expertise in Lean Manufacturing principles allows her to implement streamlined processes that reduce waste and improve productivity, ultimately delivering superior products to clients. Additionally, her proficiency in financial reporting and variance analysis enables her to make informed decisions that align with the company’s strategic goals, ensuring sustainable financial health.
Angella is also adept at cross-functional team leadership, effectively collaborating with various departments to create a cohesive approach to problem-solving and project execution. Her experience in a cGMP environment has equipped her with the knowledge to navigate complex regulatory landscapes, ensuring compliance while maintaining operational agility. As she continues to lead PCI Pharma Services toward new heights, Angella remains focused on providing an excellent customer experience, reinforcing her belief that a satisfied client is the cornerstone of long-term success in the pharmaceutical sector.
